Filter
546
Text search:
drugs
and
related
substances
act
Featured
Recommendations
58
New Publications
138
Language
Document type
No document type
339
Guidelines
78
Studies & Reports
51
Manuals
34
Strategic & Response Plan
18
Training Material
14
Situation Updates
4
Fact sheets
3
Resource Platforms
2
Infographics
2
Brochures
1
Countries / Regions
India
37
South Africa
36
Kenya
31
Nigeria
17
Western and Central Europe
17
Ethiopia
15
Ghana
15
Zambia
14
Tanzania
12
Sierra Leone
10
Global
10
Uganda
9
Nepal
9
Zimbabwe
7
Namibia
7
Liberia
6
Philippines
6
Botswana
6
Malawi
5
Rwanda
4
Bangladesh
4
Eswatini/ Swaziland
4
Myanmar / Burma
4
South–East Asia Region
4
Pakistan
3
Afghanistan
3
Germany
3
Syria
3
Indonesia
3
Ukraine
3
Eastern Europe and Central Asia
3
Eastern Europe
3
USA
2
North Macedonia
2
Lesotho
2
Sri Lanka
2
Latin America and the Carribbean
2
Asia
2
Africa
2
Southern Africa
2
Guinea
1
Burkina Faso
1
Iraq
1
Cambodia
1
Thailand
1
Papua New Guinea
1
Switzerland
1
Libya
1
Yemen
1
Bhutan
1
Poland
1
Albania
1
Russia
1
Estonia
1
Moldova
1
Georgia
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
245
Clinical Guidelines
30
Women & Child Health
24
Public Health
21
Capacity Building
12
Key Resources
8
Pharmacy & Technologies
7
Toolboxes
Mental Health
77
HIV
49
Pharmacy
48
AMR
35
TB
18
Caregiver
17
NCDs
11
COVID-19
10
Planetary Health
9
Rapid Response
8
Specific Hazards
7
Ebola
6
Global Health Education
6
Refugee
5
Conflict
3
Natural Hazards
2
Disability
1
Cholera
1
Zika
1
Health Financing Toolbox
1
Antimicrobial resistance is a global threat as it is present in all parts of the world and it means that there is a shortage of effective antibiotics to treat simple infections and diseases, also st
...
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related
...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-
...
Perspectives on Drugs
Best practice portal: standards and guidelines
recommended
The Best practice portal is a resource for professionals, policymakers and researchers in the drugs field. We provide information on the available evidence on drug-
...
Perspectives on Drugs
Indian markets caused a stir across the country.1
According to the Centre for Science and the Environment (CSE), a respected New Delhi-based NGO, most honey brands
sold in India contained varying amounts of antibiotics. Their consumption over time
...
Three Years After Enactment of the Drug Quality and Security Act
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
A.55 Medicines and Related Substances Act, 2013 | No. 8 of 2013 | An
...
Policy Brief, Updated in March 2017
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded
...